4-CHLORO-1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID
- $65 - $1046
- Product name: 4-CHLORO-1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID
- CAS: 877964-38-0
- MF: C6H6ClNO2
- MW: 159.57
- EINECS:
- MDL Number:MFCD07850245
- Synonyms:4-CHLORO-1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID;1H-Pyrrole-2-carboxylic acid, 4-chloro-1-methyl-
4 prices
Selected condition:
Brand
- AK Scientific
- ChemBridge Corporation
- Crysdot
- TRC
Package
- 50mg
- 1g
- 5g
- ManufacturerAK Scientific
- Product number9354CQ
- Product description4-Chloro-1-methyl-1H-pyrrole-2-carboxylicacid
- Packaging5g
- Price$1046
- Updated2021-12-16
- Buy
- ManufacturerChemBridge Corporation
- Product numberBB-4045702
- Product description4-chloro-1-methyl-1H-pyrrole-2-carboxylicacid 95%
- Packaging1g
- Price$185
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11037277
- Product description4-Chloro-1-methyl-1H-pyrrole-2-carboxylicacid 97%
- Packaging1g
- Price$564
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberC373978
- Product description4-chloro-1-methyl-1H-pyrrole-2-carboxylicacid
- Packaging50mg
- Price$65
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 9354CQ | 4-Chloro-1-methyl-1H-pyrrole-2-carboxylicacid | 5g | $1046 | 2021-12-16 | Buy |
ChemBridge Corporation | BB-4045702 | 4-chloro-1-methyl-1H-pyrrole-2-carboxylicacid 95% | 1g | $185 | 2021-12-16 | Buy |
Crysdot | CD11037277 | 4-Chloro-1-methyl-1H-pyrrole-2-carboxylicacid 97% | 1g | $564 | 2021-12-16 | Buy |
TRC | C373978 | 4-chloro-1-methyl-1H-pyrrole-2-carboxylicacid | 50mg | $65 | 2021-12-16 | Buy |
Properties
Boiling point :305.9±22.0 °C(Predicted)
Density :1.39±0.1 g/cm3(Predicted)
pka :4.17±0.41(Predicted)
Density :1.39±0.1 g/cm3(Predicted)
pka :4.17±0.41(Predicted)
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|